Drug-induced sleep apnea is a safe and effective means to bring about sleep quickly with few side-effects

August 13, 2014, University of Pennsylvania School of Medicine
Illustration of obstruction of ventilation. Credit: Habib M’henni / public domain

(Medical Xpress)—Researchers from Penn Medicine have developed a safe and effective technique for inducing sleep in patients with severe obstructive sleep apnea. The new procedure, known as drug-induced sleep endoscopy (DISE), uses progressive doses of anesthesia to pharmacologically induce sleep to the point of the obstruction-causing apnea in a short time frame without a dip in blood oxygen level and with few side effects.

The Penn team recently tested the procedure in 97 patients with severe sleep apnea who were candidates for transoral robotic resection of the tongue, the removal of a section the tongue where it meets the epiglottis to prevent the tongue from obstructing the airway during sleep, the most common surgical procedure for the treatment of severe sleep apnea. Study results are reported in Anesthesia and Analgesia.

TransOral Robotic Surgery (TORS) was originally developed by Penn head and neck surgeons for the removal of benign and malignant tumors of the mouth and throat.

"The Continuous Positive Airway Pressure (CPAP) mask does not provide relief for every patient with severe sleep apnea and daily compliance can also be difficult for some patients," says Joshua Atkins, MD, PhD, lead author on the study and director of Anesthesia for Head and Neck Surgery. "In order to evaluate patients for surgery, we need to visualize the obstruction, often quickly and in an office visit, outside of the sleep lab."

DISE allows physicians to recreate the obstruction in that environment. The new procedure helps pinpoint the proper doses and timing of propofol – a short-acting drug commonly used to induce the anesthetic state– to safely and quickly bring patient's to the point during their sleep that this problem would occur.

DISE uses a Penn-developed algorithm that employs the patient's age and weight to determine the appropriate starting dose and the time and dose of a secondary infusion of anesthetic in order to smoothly increase drug levels over the range associated with obstruction. This smooth increase avoids overdosing and provides predictable procedure times.

Of the patients in the study, the median time to obstruction using DISE was 3.8 minutes. Previous studies, not using DISE, cite an average time to obstruction of 6.2 minutes. Oxygen saturation, the amount of oxygen in the blood, was also much better using DISE at 91 percent than during most sleep studies which range at about 80 percent for the standard sleep apnea patient. All patients completed DISE safely, with no adverse events. While other studies have demonstrated equivalent safety at the expense of longer procedure times, or equivalent procedure times at the expense of more adverse airway events, the current study achieves both.

"DISE is a niche procedure with a growing number of clinical reports in the literature," says Atkins. "We have shown here that it can be a safe and effective means of assessing for surgery to treat severe in a way that reduces the reliance on provider experience to estimate the proper levels of anesthetic, improving care and minimizing variability between providers."

Explore further: New anesthesia technique helps show cause of obstruction in sleep apnea

More information: Anesthesia and Analgesia, journals.lww.com/anesthesia-an … ced_Sleep.98434.aspx

Related Stories

New anesthesia technique helps show cause of obstruction in sleep apnea

July 29, 2014
A simplified anesthesia procedure may enable more widespread use of preoperative testing to demonstrate the cause of airway obstruction in patients with severe sleep apnea, suggests a study in Anesthesia & Analgesia.

New surgical tool may help sleep apnea sufferers, research finds

August 27, 2013
A Wayne State University researcher's innovative use of a new tool may make surgery a more viable option for sufferers of obstructive sleep apnea/hypopnea syndrome (OSAHS).

No apparent link between sleep apnea and cancer

August 5, 2014
Obstructive sleep apnea, in which people stop breathing for short periods while sleeping, affects about 5% of Canadian adults aged 45 years or older and can negatively affect health. More than 1 in 5 adult Canadians have ...

People with sleep apnea may be at higher risk of pneumonia

March 3, 2014
People with sleep apnea appear to be at higher risk of pneumonia than people without, according to a study published in CMAJ (Canadian Medical Association Journal).

Study links severe sleep apnea to increased risk of stroke, cancer and death

April 14, 2014
A new study shows that moderate to severe obstructive sleep apnea is independently associated with an increased risk of stroke, cancer and death.

CPAP superior to supplemental oxygen for BP reduction in obstructive sleep apnea

June 11, 2014
Continuous positive airway pressure (CPAP), the most widely prescribed therapy for treatment of obstructive sleep apnea, resulted in significantly lower blood pressure compared to either nocturnal supplemental oxygen or an ...

Recommended for you

Synthetic cannabinoid reduces sleep apnea

November 29, 2017
A synthetic version of a molecule found in the cannabis plant was safe and effective in treating obstructive sleep apnea in the first large, multi-site study of a drug for the sleep disorder funded by the National Institutes ...

Sleeping through the snoring: Researchers identify neurons that rouse the brain to breathe

November 2, 2017
A common and potentially serious sleep disorder, obstructive sleep apnea affects at least one quarter of U.S. adults and is linked to increased risk of diabetes, obesity and cardiovascular disease. In a paper published today ...

Remede system approved for sleep apnea

October 9, 2017
(HealthDay)—The Remede sleep system, an implanted device that treats central sleep apnea by activating a nerve that sends signals to the diaphragm to stimulate breathing, has been approved by the U.S. Food and Drug Administration.

Inflammation may precede sleep apnea, could be treatment target

September 1, 2017
Inflammation is traditionally thought of as a symptom of sleep apnea, but it might actually precede the disorder, potentially opening the door for new ways to treat and predict sleep apnea, according to researchers.

More evidence: Untreated sleep apnea shown to raise metabolic and cardiovascular stress

August 31, 2017
Sleep apnea, left untreated for even a few days, can increase blood sugar and fat levels, stress hormones and blood pressure, according to a new study of sleeping subjects. A report of the study's findings, published in the ...

Sleep patterns contribute to racial differences in disease risk

August 18, 2017
Poor sleep patterns could explain, in part, the differences in the risk of cardiometabolic disease between African-Americans and European-Americans, according to a new study published in Proceedings of the National Academy ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.